Risk stratification and prognosis determination using (18)F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis. (Q38182746)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 January 2014

Language	Label	Description	Also known as
English	Risk stratification and prognosis determination using (18)F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis.	scientific article published on 25 January 2014

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24472411%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

Risk stratification and prognosis determination using (18)F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24472411%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

systematic review

1 reference

based on heuristic

inferred from title

endometrial cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Giorgio Treglia

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24472411%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24472411%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Haleh Ghooshkhanei

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24472411%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Golnaz Sabouri

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24472411%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Rozita Davoodi

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24472411%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

0 references

publication date

25 January 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24472411%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24472411%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

132

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24472411%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

669-676

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24472411%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24472411%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Current therapy of patients with endometrial carcinoma. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Endometrial cancer: prognostic significance of risk classification based on pre-intraoperative findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

What is the impact of cervical invasion on lymph node metastasis in patients with stage IIIC endometrial cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients: systematic review and meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Accuracy of 18F-FDG PET/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients: systematic review and meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Meta-DiSc: a software for meta-analysis of test accuracy data.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[¹⁸F]fluoro-17β-oestradiol PET.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET--initial experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Post-treatment [¹⁸F]FDG maximum standardized uptake value as a prognostic marker of recurrence in endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

FDG PET for the assessment of myometrial infiltration in clinical stage I uterine corpus cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Metabolic tumor volume by 18F-FDG PET/CT is prognostic for stage IVB endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

The preoperative SUVmax is superior to ADCmin of the primary tumour as a predictor of disease recurrence and survival in patients with endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

[SUVmax measured by 18F FDG PET/CT in the primary tumor in relation to clinical and pathological features of endometrial cancer].

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.039

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38182746&oldid=2146917051"